Preparation method of shiga-like toxin Stx1B oral vaccine and product of shiga-like toxin Stx1B oral vaccine
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING UNIV
- Publication Date
- 2012-07-18
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of bioengineering, and in particular relates to a preparation method of a Shiga-like toxin Stx1B oral vaccine and the prepared Stx1B oral vaccine. Background technique
[0002] Escherichia coli ( Escherichia coli ) O157: H7 is a serotype of enterohaemorrhagic Escherichia coli. E. coli O157: H7 infection can produce toxins to kill vero cells. The toxin produced is Shiga-like toxin (Stx), which mainly acts on pigs or humans. Colon and ileum cells, the main symptom after infection of pigs is porcine edema disease. Stx contains 1 A subunit and 5 B subunits, forming a complex toxin of A-5B structure. The A subunit is the virulence unit of Stx, which has the activity of RNA-N-terminal glycosidase, which can interfere with the synthesis of intracellular proteins and cause cell damage and death. The B subunit is non-toxic, but it can bind to cells with a specific receptor (Gb3), produce specific antibodies, and then combin...